A Clinical Trial to study the benefit of the drug Prostaglandin E1 (a vessel that basically dilates the blood vessels) in patients who undergo Living Donor Liver Transplantatio
Phase 3
Completed
- Conditions
- Health Condition 1: null- Patients with acute or chronic liver failure undergoing liver transplantation
- Registration Number
- CTRI/2013/09/003991
- Lead Sponsor
- Sudhindran S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
All patients undergoing live Donor liver transplantation
Exclusion Criteria
ABO incompatible liver transplantation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method